Skip Navigation

Cardiovascular Research 2003 57(1):147-157; doi:10.1016/S0008-6363(02)00695-8
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zhang, D.
Right arrow Articles by Zassenhaus, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, D.
Right arrow Articles by Zassenhaus, H. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy

Dekui Zhanga, Justin L. Motta, Patricia Farrarb, Jan S. Ryersec, Shin-Wen Changa, Melissa Stevensa, Grace Dennigera and Hans Peter Zassenhausa,*

aDepartment of Molecular Microbiology and Immunology, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, St. Louis, MO 63104, USA
bDepartment of Comparative Medicine, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, St. Louis, MO 63104, USA
cDepartment of Pathology, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, St. Louis, MO 63104, USA

* Corresponding author. Tel.: +1-314-577-8444; fax: +1-314-773-3403. zassenp{at}slu.edu

Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4–5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway.

KEYWORDS Aging; Apoptosis; Cardiomyopathy; Mitochondria; Sequence (DNA/RNA/prot)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. G. Bensch, J. L. Mott, S.-W. Chang, P. A. Hansen, M. A. Moxley, K. T. Chambers, W. de Graaf, H. P. Zassenhaus, and J. A. Corbett
Selective mtDNA mutation accumulation results in {beta}-cell apoptosis and diabetes development
Am J Physiol Endocrinol Metab, April 1, 2009; 296(4): E672 - E680.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
C. Ricci, V. Pastukh, J. Leonard, J. Turrens, G. Wilson, D. Schaffer, and S. W. Schaffer
Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C413 - C422.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
Y.-G. Yao, F. M. Ellison, J. P. McCoy, J. Chen, and N. S. Young
Age-dependent accumulation of mtDNA mutations in murine hematopoietic stem cells is modulated by the nuclear genetic background
Hum. Mol. Genet., February 1, 2007; 16(3): 286 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Kubota, T. Kasahara, T. Nakamura, M. Ishiwata, T. Miyauchi, and T. Kato
Abnormal Ca2+ Dynamics in Transgenic Mice with Neuron-Specific Mitochondrial DNA Defects.
J. Neurosci., November 22, 2006; 26(47): 12314 - 12324.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. Aure, G. Fayet, J. P. Leroy, E. Lacene, N. B. Romero, and A. Lombes
Apoptosis in mitochondrial myopathies is linked to mitochondrial proliferation
Brain, May 1, 2006; 129(5): 1249 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. A. Hacker, S. H. McKiernan, P. S. Douglas, J. Wanagat, and J. M. Aiken
Age-related changes in cardiac structure and function in Fischer 344 x Brown Norway hybrid rats
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H304 - H311.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Zhang, J. L. Mott, S.-W. Chang, M. Stevens, P. Mikolajczak, and H. P. Zassenhaus
Mitochondrial DNA mutations activate programmed cell survival in the mouse heart
Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2476 - H2483.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. R. Duchen
Roles of Mitochondria in Health and Disease
Diabetes, February 1, 2004; 53(90001): S96 - 102.
[Abstract] [Full Text]

Home page
 Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Mitochondrial Medicine - Cardiomyopathy Caused by Defective Oxidative Phosphorylation
Ann. Clin. Lab. Sci., October 1, 2003; 33(4): 371 - 395.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.